CA Patent

CA2781254C — Carboxyvinyl polymer-containing nanoparticle suspensions

Assigned to Novartis AG · Expires 2016-06-28 · 10y expired

What this patent protects

The present invention generally relates to suspension compositions having a carboxyvinyl polymer such as a carbomer, a galactomannan such as guar, and a borate compound. A sparingly soluble particulate compound such as nepafenac is also included in the compositions. In some embo…

USPTO Abstract

The present invention generally relates to suspension compositions having a carboxyvinyl polymer such as a carbomer, a galactomannan such as guar, and a borate compound. A sparingly soluble particulate compound such as nepafenac is also included in the compositions. In some embodiments, the sparingly soluble particulate compound has a small particle size to enhance bioavailability of the compound.

Drugs covered by this patent

Patent Metadata

Patent number
CA2781254C
Jurisdiction
CA
Classification
—
Expires
2016-06-28
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.